FDA Approval Activities for this Drug…

Abilify (aripiprazole) Tablets, Otsuka America Pharmaceutical, NDA 21-436/S1 Abilify (aripiprazole) Tablets, 2, 5, 10, 15, 20 and 30 mg, Otsuka Pharmaceutical Co., Ltd. NDA 21-436 Abilify (aripiprazole) Tablets, Otsuka | Abilify (aripiprazole) Tablets, Otsuka Maryland Research, New or Modified Indication | Abilify (aripiprazole) Oral Solution, Otsuka America Pharma, Approval | Abilify (aripiprazole) Tablets, Otsuka Maryland Research, New or Modified Indication & Labeling Revision | Abilify Oral Solution, Otsuka Maryland Research, Labeling Revision

For the latest approval information, please locate this drug using this index.